Biogen vs GE HealthCare Technologies
Biogen (BIIB), health care, and GE HealthCare Technologies (GEHC), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.
Biogen and GE HealthCare Technologies are valued at about the same: $37.1B and $37B. Biogen trades at 109 times earnings and GE HealthCare Technologies at 17.3. Over the past year Biogen's share price has moved +49.1% and GE HealthCare Technologies's +16.8%.
Key facts
- Biogen market value
- $37.1B
- GE HealthCare Technologies market value
- $37B
- Biogen P/E
- 109
- GE HealthCare Technologies P/E
- 17.3
- Biogen revenue
- $9.9BFY to 2025-12-31
- GE HealthCare Technologies revenue
- $20.6BFY to 2025-12-31
- Superinvestors holding both
- 0
Market values as of .
| Measure | Biogen | GE HealthCare Technologies |
|---|---|---|
| Sector | Health Care | Health Care |
| Country | ||
| Fiscal year ends | 2025-12-31 | 2025-12-31 |
| Size | ||
| Market cap | $37.1Bhigher | $37Blower |
| Revenue | $9.9Blower | $20.6Bhigher |
| Earnings | $1.3Blower | $2.1Bhigher |
| Employees | 7,500lower | 54,000higher |
| Total assets | $29.4Blower | $36.9Bhigher |
| Valuation | ||
| P/E | 109higher | 17.3lower |
| P/S | 3.7higher | 1.8lower |
| P/B | 2.0lower | 3.2higher |
| Dividend yield | 0.00%lower | 0.17%higher |
| Profitability | ||
| Operating margin | — | 13.4% |
| Balance sheet | ||
| Net assets | $18.3Bhigher | $10.4Blower |
| Total liabilities | $11.2Blower | $26.3Bhigher |
| Total debt | $6.3Blower | $10.5Bhigher |
| Cash on hand | $3Blower | $4.5Bhigher |
| Price change | ||
| Today | -0.34%higher | -1.35%lower |
| 1 year | +49.1%higher | +16.8%lower |
Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.
Which superinvestors hold them
From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.
Both (0)
None of the tracked investors.
Biogen only (4)
- Primecap team2.1%
- Samantha McLemore1.9%
- Andrew Spokes0.8%
- Joel Greenblatt0.1%
GE HealthCare Technologies only (11)
- Nelson Peltz4.7%
- Harry Burn2.4%
- Dodge & Cox team1.7%
- Bill Nygren1.3%
- Steven Romick0.7%
- Josef Lakonishok0.4%
- Richard Pzena0.2%
- Mark Boyar0.2%
- Temasek0.2%
- Jeremy Grantham (co-founder)0.1%
- Christopher Bloomstran<0.1%
Percentages are each holding's share of that investor's reported portfolio. Who owns BIIB · Who owns GEHC
More on Biogen
Further comparisons
Biogen against its closest peers
GE HealthCare Technologies against its closest peers
Learn
Questions and answers
Which is bigger, Biogen or GE HealthCare Technologies?
By market value, Biogen is the larger: $37.1B against $37B for GE HealthCare Technologies. By revenue in its latest fiscal year, GE HealthCare Technologies is the larger: $20.6B against $9.9B for Biogen.
Which has the higher P/E ratio?
Biogen: 109, against 17.3 for GE HealthCare Technologies. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.
Which has the higher dividend yield?
GE HealthCare Technologies: 0.17%, against 0.00% for Biogen. Dividend yield is the last twelve months' dividends as a share of today's share price.
Which has more debt?
GE HealthCare Technologies: $10.5B, against $6.3B for Biogen. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.
Which superinvestors own both Biogen and GE HealthCare Technologies?
None of the tracked superinvestors holds both in their latest 13F filing. 4 hold Biogen and 11 hold GE HealthCare Technologies.
Cite this page
Funkfolio, “Biogen vs GE HealthCare Technologies”, data as of 18 November 2026. https://funkfolio.com/compare/biib-vs-gehc
Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.